Two Seas Capital LP Arbutus Biopharma Corp Transaction History

Two Seas Capital LP

$5.03 Billion
Q3 2025

A detailed history of Two Seas Capital LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Two Seas Capital LP holds 10,991,261 shares of ABUS stock, worth $49.7 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

10,991,261

Previous 10,443,317 5.25%

Holding current value

$49.7 Million

Previous $32.3 Million 54.64%

% of portfolio

0.99%

Previous 0.6%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.08 - $4.9 $1.69 Million - $2.68 Million	547,944 Added 5.25%	10,991,261 $49.9 Million
Q2 2025 Aug 13, 2025	BUY	$2.88 - $3.61 $2.81 Million - $3.53 Million	977,361 Added 10.33%	10,443,317 $32.3 Million
Q1 2025 May 15, 2025	BUY	$3.06 - $3.59 $2.22 Million - $2.6 Million	725,000 Added 8.29%	9,465,956 $33 Million
Q4 2024 Feb 14, 2025	BUY	$3.18 - $4.2 $1.12 Million - $1.48 Million	353,568 Added 4.22%	8,740,956 $28.6 Million
Q3 2024 Nov 14, 2024	SELL	$3.12 - $4.56 $575,212 - $840,695	-184,363 Reduced 2.15%	8,387,388 $32.3 Million

Q2 2024 Aug 14, 2024	BUY	$2.52 - $3.63 $1.84 Million - $2.65 Million	729,824 Added 9.31%	8,571,751 $26.5 Million
Q1 2024 May 15, 2024	SELL	$2.26 - $2.92 $2.71 Million - $3.5 Million	-1,200,000 Reduced 13.27%	7,841,927 $20.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $2.54 $1.29 Million - $1.93 Million	761,109 Added 9.19%	9,041,927 $22.6 Million
Q2 2023 Aug 14, 2023	BUY	$2.24 - $3.06 $1.83 Million - $2.5 Million	816,094 Added 10.93%	8,280,818 $19 Million
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $88,015 - $122,353	-39,469 Reduced 0.53%	7,464,724 $22.6 Million
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $3.53 Million - $5.27 Million	1,850,276 Added 32.73%	7,504,193 $17.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $4.05 Million - $6.2 Million	2,152,041 Added 61.45%	5,653,917 $10.8 Million
Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $2.58 Million - $4.13 Million	1,302,807 Added 59.24%	3,501,876 $9.49 Million
Q1 2022 May 13, 2022	BUY	$2.42 - $3.98 $3.32 Million - $5.47 Million	1,373,500 Added 166.37%	2,199,069 $6.55 Million
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $2.57 Million - $3.81 Million	825,569 New	825,569 $3.21 Million

Others Institutions Holding ABUS

# of Institutions

194

Shares Held

118M

Call Options Held

2.67M

Put Options Held

693K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $678M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.

Account

Two Seas Capital LP Arbutus Biopharma Corp Transaction History